ZS Pharma, Inc., a bio-pharmaceutical company, has submitted the New Drug Application (NDA) at FDA for its new medicine ZS-9.
The drug would be used for the treatment of hyperkalemia.
View the full release here.
ZS Pharma, Inc., a bio-pharmaceutical company, has submitted the New Drug Application (NDA) at FDA for its new medicine ZS-9.
The drug would be used for the treatment of hyperkalemia.
View the full release here.